Seraphina Therapeutics, Inc.
PrivateLast Round
Series A
Extension
Oct 13, 2021
Total Funding Raised
$11.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Seraphina Therapeutics, Inc. is a health and wellness company that develops evidence-driven consumer health products, including fatty acid supplements and nutritional interventions, focused on healthy aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seraphina Therapeutics, Inc. Comparables
Compare Seraphina Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elysium Health | 84% | |
| DoNotAge | 79% | |
| NOVOS | 78% | |
Seraphina Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 13, 2021 | ||||
| Series A | May 18, 2020 |
Key People
Founding team and executive leadership
Seraphina Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Domain Associates | Series A Extension, Series A |
| Cue Ball | Series A Extension |
| BioBrit | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 161% MoM, reaching 5.4K.
- Jun 20, 2026
Monthly visitors increased 61% MoM.
Seraphina Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Seraphina Therapeutics, Inc.'s valuation, stock price, and market status.